Effective Immediately: OncoSec Names Former Advaxis Exec as New CEO Post author:Sam Post published:November 7, 2017 Post category:BioPharma OncoSec Medical today announced the appointment of Daniel J. O’Connor as CEO of the Company. Source: BioSpace You Might Also Like Boston's SV Life Sciences Unveils Name Change, Debuts $400M Fund for Biotech April 12, 2017 <b>Bluechiip Ltd</b> Change Of Share Registry July 16, 2017 Merck KGaA, Pfizer's Lung Cancer Drug Flunks Late-Stage Trial February 15, 2018